40 results
8-K
EX-99.1
ZLAB
Zai Lab Limited
9 Nov 22
Zai Lab Announces Third Quarter 2022
4:13pm
) polymerase (PARP) 1/2 inhibitor. It is the only PARP inhibitor approved in the United States, the European Union, and China as a first-line maintenance
8-K
EX-99.1
ZLAB
Zai Lab Limited
27 Sep 22
Entry into a Material Definitive Agreement
8:08am
and Peking Union Medical College. “This represents one of the biggest challenges faced by gynecologic oncologists with significant unmet needs … , Canada, Switzerland and the European Union. For more information on the company’s marketed products and robust pipeline, visit www.seagen.com and follow
8-K
EX-99.1
ZLAB
Zai Lab Limited
9 Aug 22
Zai Lab Announces Second Quarter 2022
12:00am
. It is the only PARP inhibitor approved in the United States, the European Union, and mainland China (hereinafter, “China”) as a monotherapy for patients
8-K
EX-99.1
xmbqadp
10 May 22
Zai Lab Announces First Quarter 2022
4:10pm
8-K
EX-99.1
421 fywkjq1cu9a4m
1 Mar 22
Results of Operations and Financial Condition
4:17pm
8-K
EX-99.3
hfkv99bht
9 Nov 21
Zai Lab and Blueprint Medicines Announce Strategic Collaboration and License
4:26pm
8-K
EX-99.1
aso nlp9n1f8ug7nmidn
9 Aug 21
Zai Lab Announces Second Quarter 2021
4:06pm
10-Q
EX-10.1
2qqmb
10 May 21
Quarterly report
8:58am
10-Q
EX-10.2
l6g0k1i n6tpy
10 May 21
Quarterly report
8:58am
8-K
EX-99.1
c8tzcs71
10 May 21
Zai Lab Reports First Quarter 2021 Financial Results
8:55am
424B5
x3z9b 2e4kh8aei0gqk
21 Apr 21
Prospectus supplement for primary offering
4:45pm
8-K
EX-1.1
e2rbsbc3k8gw9na
21 Apr 21
Financial Statements and Exhibits
3:00pm
8-K
EX-1.2
tb8vjf
21 Apr 21
Financial Statements and Exhibits
3:00pm
424B5
7uhfuhqa
19 Apr 21
Prospectus supplement for primary offering
4:57pm
8-K
EX-99.1
9v8de07
1 Mar 21
Zai Lab Announces Financial Results
7:01am
10-K
EX-10.21
uddvoz
1 Mar 21
Annual report
12:00am